Sumitha Celin T, Allen Gnana Raj G, Prathima T S, Balamurali M M
Department of Chemistry and Research Centre, Scott Christian College (Autonomous), Nagercoil, Tamilnadu, India.
Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Chennai, Tamilnadu, India.
Front Chem. 2025 Feb 3;13:1491598. doi: 10.3389/fchem.2025.1491598. eCollection 2025.
The photophysical properties of tris(polypyridyl)ruthenium(II) complex [Ru(dmbpy)] [dmbpy = 4,4'-dimethyl-2,2'-bipyridine] were investigated and compared with [Ru(bpy)] following both experimental and computational approaches. The variations in the electronic properties of the complex in the ground and excited states were determined by density functional theory (DFT) methods, and their effects on the anticancer, antioxidant, and antimicrobial activities were also evaluated by molecular docking and dynamic simulation studies. The potential of these complexes to serve as bioanalytes was investigated by their ability to bind with quinones, the well-known electron mediators in numerous light-driven reactions. Following the above, the anticancer properties were evaluated against breast cancer-related proteins. The results revealed that the complex possesses comparable anticancer and antioxidant potential to that of [Ru(bpy)]. The physical, electronic, and biological properties of this complex depend on the nature of the ligands and the medium of investigation. Herein, the potential applications of [Ru(bpy)] in clinical diagnostics as antioxidants and therapeutic agents were evaluated.
采用实验和计算方法研究了三(多吡啶基)钌(II)配合物[Ru(dmbpy)] [dmbpy = 4,4'-二甲基-2,2'-联吡啶]的光物理性质,并与[Ru(bpy)]进行了比较。通过密度泛函理论(DFT)方法确定了配合物基态和激发态电子性质的变化,并通过分子对接和动态模拟研究评估了它们对抗癌、抗氧化和抗菌活性的影响。通过这些配合物与醌(众多光驱动反应中著名的电子介质)结合的能力,研究了它们作为生物分析物的潜力。在此基础上,评估了其对乳腺癌相关蛋白的抗癌特性。结果表明,该配合物具有与[Ru(bpy)]相当的抗癌和抗氧化潜力。该配合物的物理、电子和生物学性质取决于配体的性质和研究介质。本文评估了[Ru(bpy)]在临床诊断中作为抗氧化剂和治疗剂的潜在应用。